Forward Therapeutics, Inc

Forward Therapeutics is a clinical-stage biopharmaceutical company advancing a pipeline of internally-discovered novel, oral small molecule therapies for inflammation-driven diseases. The company builds its portfolio using SWIFT, a data-driven drug discovery engine designed to unlock high-potential, hard-to-drug targets, an approach that combines curated, drug-like libraries with elaborated screening assays and deep structural insights to enable rapid hit finding and lead optimization.